Search results “New cancer research stanford ucsf”
UCSF - Helen Diller Family Comprehensive Cancer Center
Learn more about how UCSF's expert team is advancing cancer care and research worldwide.
Ucsf Prostate Cancer - What's New In Prostate Cancer Treatment? | Dana-Farber Cancer Institute
Ucsf Prostate Cancer - What's New In Prostate Cancer Treatment? | Dana-Farber Cancer Institute. For alternative option go to https://wp.me/p9xQ8n-55 ucsf prostate cancer - prostate cancer overview. ucsf prostate cancer radiation Or poster at the annual UCSF Prostate Cancer research retreat 2013 UCSF Prostate Cancer Retreat ucsf prostate cancer nomogram The authors thank Jeanette Broering, Hazel Dias, Alex Ignatov, Sarah Joost and Frank Stauf for operating and managing the UCSF Urologic Oncology Outcomes Database and Nannette Perez for supporting the UCSF prostate cancer active surveillance cohort The hallmark of research in the UCSF Prostate Cancer Program is innovative scientific approaches to important problems in prostate cancer. Prostate cancer decisions: mayo clinic radio. Esmo 2017: prostate cancer highlights. Lifestyle and Diet May Stop or SuMMarY heaLthY proState CaNCer diet 23 frequently asked Questions University of California, San Francisco Patient Advocates Stan Rosenfeld, ucsf prostate cancer diet. He is the leader of the Genitourinary Medical Oncology Program and an investigator with the UCSF Prostate Cancer Program. The hallmark of research in the UCSF Prostate Cancer Program is innovative scientific approaches to important problems in prostate cancer. 2015 UCSF Prostate Cancer Program Retreat. The authors thank Jeanette Broering, Hazel Dias, Alex Ignatov, Sarah Joost and Frank Stauf for operating and managing the UCSF Urologic Oncology Outcomes Database and Nannette Perez for supporting the UCSF prostate cancer active surveillance cohort. Search Results For: ucsf prostate cancer active surveillance. Poster presentation, UCSF Prostate Cancer Retreat, San Francisco, CA, on May 23, 2011 PROCEEDINGS: 1993 Wyeth Pediatrics: Pediatric and adolescent gynecology: a challenge for the '90s. 3/01: UCSF Prostate Cancer Retreat, “Interrupting assembly of nuclear hormone receptor transcriptional activation complexes: Implications for drug development”. Place Clinical Science Poster, UCSF Prostate Cancer Retreat. June 16, 2010, Josh Stuart, UCSF Prostate Cancer Retreat. 6/01-5/02: Co-PI (with Robert Fletterick), UCSF Prostate Cancer Research Program, “Novel. Best Poster presentation award at the Annual UCSF prostate Cancer Research Retreat-2016. Or poster at the annual UCSF Prostate Cancer research retreat. 2011 UCSF Prostate Cancer Research Retreat. 5 Million for UCSF Prostate Cancer Research. Search Results For: ucsf prostate cancer radiation. Expert opinions in prostate cancer brazil 2017. What's new in prostate cancer treatment? Patients with advanced prostate cancer are currently treated with combinations and sequences of immunotherapies hormonal approaches and chemotherapy. Freedland presented "nutrition and prostate cancer: what we think we know and what we actually know" at the 22nd annual scottsdale prostate cancer symposium on thursday march 16 2017. Nutrition and prostate cancer what we think we know and what we actually know. Body rig research highlights - treatment of prostate cancer at ucsf using different tools and techniques such as hifu prostate hyperthermia micropet / ct images of psma and hyperpolarized c-13 mr. Localized prostate cancer: progress toward personalized care. Rethinking prostate cancer at ucsf with matthew cooperberg, md. In the era of prostate cancer screening mortality rates have fallen 40 percent. In the era of prostate cancer screening mortality rates have fallen 40 percent. In the era of prostate cancer screening mortality rates have fallen 40 percent. Viewing prostate cancer aggressiveness in a unique way. #UcsfProstateCancer ucsf prostate cancer treatment, ucsf prostate cancer diet, ucsf prostate cancer clinical trials, stanford prostate cancer, ucsf prostate cancer program, ucsf lung cancer doctors, ucsf prostatectomy Reference: https://youtu.be/dU-E-_axrZc https://www.youtube.com/playlist?list=PLLmSMVj8_5y8Mt-0eXZtUt67k3ad2OGOW https://en.wikipedia.org/wiki/Prostate_cancer https://en.wikipedia.org/wiki/University_of_California,_San_Francisco https://www.youtube.com/watch?v=oU-BAjUppfU
Views: 2567 Best Tongkat Ali
Advanced Prostate Cancer
(Visit: http://www.uctv.tv) Prostate cancer kills approximately 30,000 men in the US every year. For many, the disease is highly treatable and can be controlled with medical therapy for many years. An understanding of the factors that drive prostate cancer to become potentially lethal has led to a variety of new treatments that go far beyond standard chemotherapy approaches to cancer. Patients with advanced prostate cancer are currently treated with combinations and sequences of immunotherapies, hormonal approaches and chemotherapy. UCSF oncologist Dr. Charles J. Ryan covers the clinical and biological factors that drive treatment choice and sequence by physicians, and highlights how prostate cancer therapies are emblematic of the progress that is being made against cancer in general. Further, he addresses the challenges faced by patients and doctors and the research being done to address them. Recorded on 06/17/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28498]
Accelerate Research for a Cancer-Free World!
Researchers at UC San Francisco are leading the way in identifying new pathways to treating many types of cancer. You can be a part of this movement by contributing directly to the UCSF Helen Diller Family Comprehensive Cancer Center. Give today at http://proj.at/1anxbig
The Future of Machine Learning in Clinical Imaging
(Visit: http://www.uctv.tv/) 0:15 - Intro to Machine Learning - Marc Kohli 15:51 - Training Computers to "Look" at X-rays Using Deep Learning - Andrew Taylor 36:33 - Artificial Intelligence and the Future of Radiology - John Mongan 55:16 - Audience Questions Machine learning can augment clinical and research activities in many ways. Find out the latest on the future of machine learning in clinical imaging. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [11/2017] [Show ID: 32933]
Gynecologic Cancer Treatment
(Visit: http://www.uctv.tv/) Explore treatments, other than surgery, to treat gynecologic cancer: radiation, cytotoxic chemotherapy, targeted treatments, and immunotherapy. Recorded on 03/21/2017. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [6/2017] [Health and Medicine] [Show ID: 32079]
James Spudich (Stanford) 4: Myosin mutations and hypertrophic cardiomyopathy
James Spudich begins his talk with an early history of muscle biology, and through parts 2-4 of his talk, he moves forward to our current understanding of the molecular basis of muscle contraction and disease. https://www.ibiology.org/ibioseminars/myosin-mutations-hypertrophic-cardiomyopathy.html Talk Overview: In his last talk, Spudich focuses on work currently going on in his lab to understand how mutations in cardiac myosin cause human hypertrophic cardiomyopathy (HCM).  This is a disease characterized by a hyper-contractile heart and is the most common cause of sudden cardiac arrest in people under 35 years old.  Based on insight from a dream, Spudich realized that many of the mutations associated with HCM are in a region of the myosin molecule (the myosin mesa) that may regulate the availability of myosin heads to bind to actin and thus, regulate muscle contraction.  Spudich’s lab is now working to determine the importance of the myosin mesa in regulating cardiac contractility and, in particular, its role in HCM.   Speaker Biography: James (Jim) Spudich is the Douglass M. and Nola Leishman Professor of Cardiovascular Disease in the Department of Biochemistry at Stanford University School of Medicine.  For the past several decades, his lab has studied the structure and function of the myosin family of motor proteins.  More recently Spudich’s lab has focused on human cardiac muscle myosin and the molecular basis of hypertrophic cardiomyopathy.   Spudich received his B.S. in chemistry from the University of Illinois and his Ph.D. in biochemistry from Stanford University. He was a post-doctoral fellow at Stanford University and then at the MRC Laboratory in Cambridge where he worked with Hugh Huxley.  Spudich joined the faculty of the University of California, San Francisco from 1971-1977.  In 1977, he moved to Stanford University where he was first a professor in the Department of Structural Biology and, since 1992, has been a professor in the Department of Biochemistry.  Spudich is also an Adjunct Professor at the Institute of Stem Cell Biology and Regenerative Medicine (inStem) and the National Center for Biological Sciences (NCBS) in Bangalore, India. Spudich serves on numerous editorial and scientific advisory boards.  His research contributions have been recognized with many honors and prizes including the Albert Lasker Basic Medical Research Award in 2012, the E.B. Wilson Award from the American Society for Cell Biology in 2011, and the Biophysics Society Award for Outstanding Investigator in 2005.  He is an elected fellow of the American Association for the Advancement of Science and the American Academy of Arts and Sciences, and an elected member of the US National Academy of Sciences. Learn more about Spudich’s research here: http://spudlab.stanford.edu/
Views: 812 iBiology
UCSF: The Campaign
Through UCSF: The Campaign, we will seize this transformative moment to solve some of the world's most intractable health challenges – supporting our faculty and students to make the biggest possible impact on the health and well-being of everyone. Visit https://campaign.ucsf.edu
UCSF: Leading Revolutions in Health
UC San Francisco is leading revolutions in health through cutting-edge biomedical research, outstanding patient care and training the health care leaders of tomorrow. As the nation's preeminent university singularly focused on health, UCSF is home to five Nobel laureates, as well as thousands of scientists and clinicians who are working to solve health's biggest mysteries. UCSF Shaw Prize recipients discuss the research they and others are conducting on campus and their hopes for using that research to benefit humanity. UCSF is convening the world's brightest and most innovative minds to spur the next revolution in health: precision medicine, which aims to provide precise, predictive and transformative care to every patient, worldwide. This UCSF video includes Chinese subtitles.
Inflammatory Bowel Disease (IBD) & Stem Cell Research: Ophir Klein, UCSF
In his presentation to the California Stem Cell Agency (CIRM) governing Board, Dr. Ophir Klein, a CIRM grantee and UCSF researcher, detailed his lab’s work to understand how stem cells regulate the healing of the intestine and to eventually find cures for inflammatory bowel disease (IBD).
Doctor Discusses Possible Brain Cancer Breakthrough
CBS This Morning medical contributor Dr. David Agus talks about a possible breakthrough in cancer treatment, where the poliovirus is being used to as a possible treatment in fighting brain tumors.
Views: 443 CBSDFW
NETRF Bay Area NET Patient Education Conference - 10 Nuclear Medicine Imaging: Treatment for NETs Pe
NETRF Bay Area NET Patient Education Conference Stanford Cancer Center & NET Research Foundation 2.4.2017 www.netrf.org Thomas Hope, MD Assistant Professor in Residence in the Abdominal Imaging and Nuclear Medicine sections at UCSF and the San Francisco Veterans A airs Medical Center Dr. Thomas Hope is an assistant professor in residence in the Abdominal Imaging and Nuclear Medicine sections at UCSF and the San Francisco Veterans Affairs Medical Center. In 2007, he received his medical degree from Stanford University School of Medicine and he completed a one-year internship at Kaiser Permanente, San Francisco. From 2008-2012, Dr. Hope completed a residency in Diagnostic Radiology at UCSF, followed by a clinical fellowship in Body MRI and Nuclear Medicine from Stanford Medical Center in 2013. Dr. Hope’s main research focus is on novel imaging agents. He is the principle investigator on the Ga-68 DOTA-TOC IND at UCSF and the Ga-68 HBED-CC PSMA IND at UCSF. He plans to combine his interests in MR imaging and nuclear medicine to help further the combined modality, PET/MR.
Renal Cell Carcinoma
(Visit: http://www.uctv.tv/) In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. Dr. Won Kim reviews the epidemiology of kidney cancer (including established risk factors), the biology and pathophysiology of kidney cancer, treatment options for localized disease, and the role of systemic therapy in the treatment of advanced, metastatic disease. He also discusses the current and future role of immunotherapy in kidney cancer. Recorded on 07/15/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28502]
Cell Therapy for Cancer: Past, Present and Future
What does cell therapy in cancer look like today, and what will this exploding field look like in the future? This has been a milestone year for cell therapy, with FDA approval of the first adoptive CAR T-cell therapies for acute myeloid leukemia and some large B-cell lymphomas. But there is much more on the horizon. Watch Jeff Bluestone, PhD, president and CEO of the Parker Institute for Cancer Immunotherapy, and Crystal Mackall, MD, center director of the Parker Institute at Stanford Medicine, discuss new approaches, strategies and technologies for cell-based therapies that will continue to transform precision medicine. This talk was recorded at the Precision Medicine World Conference in January 2018 in Silicon Valley.
Prof. Donald I. Abrams MD - Cannabis and Cancer Care
Donald I. Abrams, MD. is chief of the Hematology-Oncology Division at San Francisco General Hospital and a Professor of Clinical Medicine at the University of California San Francisco. He has an Integrative Oncology consultation practice at the UCSF Osher Center for Integrative Medicine. He received an A.B. in Molecular Biology from Brown University in 1972 and graduated from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in Hematology/Oncology at the Cancer Research Institute of the University of California, San Francisco in 1980. He was one the original clinician/investigators to recognize and define many early AIDS-related conditions. He has long been interested in clinical trials of complementary and alternative medicine interventions for HIV/AIDS and cancer, including evaluations of medicinal Cannabis. In 1997 he received funding from the National Institute on Drug Abuse to conduct clinical trials of the short-term safety of cannabinoids in HIV infection. Subsequently he was granted funds by the University of California Center for Medicinal Cannabis Research to continue studies of the effectiveness of cannabis in a number of clinical conditions. He completed a placebo-controlled study of smoked cannabis in patients with painful HIV-related peripheral neuropathy as well as a study evaluating vaporization as a smokeless delivery system for medicinal. He conducted an NIDA-funded trial investigating the possible pharmacokinetic interaction between vaporized cannabis and opioid analgesics in patients with chronic pain. He is now conducting an NIH-funded trial investigating vaporized cannabis in patients with Sickle Cell disease. He co-authored the chapter on “Cannabinoids and Cancer” in the Oxford University Press Integrative Oncology text that he co-edited with Andrew Weil. He co-edits the NCI PDQ CAM Cannabinoids and Cancer website. For further credentials and a summary of the scientific evidence to be presented to the court, please see Fields of Green for ALL’s Expert Witness page.
Views: 1497 Dagga Couple
Top 10 Best Cancer
Treatment Hospitals in The World
Here are the top 10 Best Cancer Treatment Hospitals in The World 👇👇👇👇👇👇👇👇 10. Stanford Health Stanford Hospital, Stanford, California: This hospital was founded in 1968 and it is located in the California. It is a well known hospital for treatment of cancer diseases. This hospital has well experienced doctors, nurses, staff that also provides many other diseases treatment. It provides treatment of heart diseases, organ transplantation, brain diseases, cancer and various other surgeries and therapies. This hospital has yearly 40 thousand room visits. This hospital can treat 20 thousand patients yearly. This hospital also provides helicopter facility to take the patient to the hospital with only one call. 9. UCSF Medical Center, San Francisco: It is one of the leading hospital and institute in research in San Francisco, California. This hospital provides treatment for all the complex diseases. The medical institute id affiliated with the university of California and it is located in the Parnassus Heights, Mission Bay. This hospital has been ranked in the top 10 in various disease treatments including diabetes, neurology, gynecology, cancer and many more. From the Chuck Feeney, this hospital has been gifted with a donation of $100 million. This hospital is very famous for its advanced treatment of cancer. The doctors also provide awareness of cancer by providing the right information to the patients. This hospital can treat 500 patients at one time. This hospital can treat 14 different types of cancers and other major diseases. 8. Massachusetts General Hospital, Boston: It is 2nd biggest hospitals in the England and it is very famous hospital to treat cancer diseases. The research center of this hospital is located in the West End neighborhood of Boston, Massachusetts. This hospital can treat thousand patients at one time. It offers cancer treatment nationally and internationally. This hospital provides high quality and best services to cancer patient and also provides medicines to the patient. This hospital also uses chemotherapies and radio therapies to remove cancer from every body part of the patient. This hospital can treat various cancers, including bone, breast, blood, bladder and many more. 7. UCLA Medical Center, Los Angeles: This hospital was founded in 1955 and it is located in the Los Angeles, CA. This hospital had already 23 thousand entries in surgical treatment. This hospital treat 10 thousand patients annually and 15 thousand surgeries. It is also a teaching institute. This hospital is also ranked in adult and children special treatment. This hospital also known as the Ronald Reagan Medical Center. The department of this hospital works 24 hours to treat various diseases. This hospital also uses latest and new technology to treat various types of cancer diseases. This hospital also has very experienced doctors, that prevent the further possibility of cancer and control it at the first stage. This hospital provides various treatments at a reasonable rate. 6. Johns Hopkins Hospital, Baltimore: It is one of the most famous hospitals in the world. It is one of the best institute and hospital for treatment of cancer. This hospital is located in the Baltimore, USA. It has also well experienced and qualified doctors and trainers. The hospital also provides huge types of treatment plans for the patients. The doctors and research team are given different tasks to diagnose and treat cancer from anyone’s life. With the new and advanced technique, the doctors can make it possible to cure the Genetic abnormalities and also the cancer diseases. It helps to treat various types of cancer including, colon, gyne, breast, head cancer and much more. It also provides various programs to treat various diseases and cancer. This hospital also provides another treatment, including stem cell transplantation, DNA repair, regulating cell cycle and much more. 5. Seattle Cancer Care Alliance or the University of Washington Medical Center: SCCA is located in the Seattle, Washington. This hospital was started in 1998 by the Fred Hutchinson. This hospital has well experienced surgeons, doctors, oncologists and other faculty. In 2014, this hospital treat 7 thousand patients. The doctors help to treat many cancers, including breast cancer, lung, colon and many other cancers successfully. In 2015, this hospital has been named in the list of 5 best cancer treatment hospitals. This hospital also performed the transplant program of the Fred Hutch Bone Marrow. The vice president of the hospital is Norm Hubbard. This hospital uses 20 different methods to treat cancer and it also provides transplantation and bone marrow operation facility. This hospital also has its branches in various places of the Washington state. 4. Dana Farber and Brigham and Women’s Cancer Center, Boston: This hospital is located in the Boston, Massachusetts and it is founded in 1997. It helps to treat a wide variety of cancer diseases.
Views: 441 WORLD WiNNER360
UCSF Radiology: Breast Cancer Imaging and Clinical Trials at UCSF
UCSF Radiologist Dr Bonnie Joe describes how UCSF not only offers breast cancer imaging, but breast cancer clinical trials as well.
Views: 125 UCSF Imaging
Cancer Cure Testimony 2018
cancer cure high alkaline .. Cure Cancer With Vitamin B17 .. cancer cure orginic foods .. cannabis oil cure cancer 2018 .. New Groundbreaking Cancer Treatments .. New Cancer Treatment 2018
Views: 2522 Captain Nowledge
Atrial Fibrillation for the Interested Layperson
(Visit: http://www.uctv.tv/) UCSF cardiologist Dr. Gregory Marcus covers the basic mechanisms underlying atrial fibrillation - an irregular, often rapid heart rate. He discusses the consequences of the disease, and the various therapies available for treatment. Gregory is the Director of Clinical Research in the Division of Cardiology at UCSF. Recorded on 06/03/2015. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2015] [Health and Medicine] [Show ID: 29727]
The Role of Technology, Data and Innovation in Improving Global Cancer
Panel: “The Role of Technology, Data and Innovation in Improving Global Cancer” Ami Bhatt, MD, PhD, Stanford University (Moderator) Megan Huchko, MD, MPH, UCSF Eduardo Zambrano, MD, MSC, Stanford University Sherry Wren, MD, Stanford University Tracy Sherertz, MD, UCSF Kris Sankaran, Stanford University 4th Annual Symposium on Global Cancer Research Hilton San Francisco Union Square April 8, 2016
Views: 27 GlobalOnc
The Science and Art of Integrative Medicine
(Visit: http://www.uctv.tv/) Explore the research behind the science of integrative medicine with Dr. Kevin Barrows, UCSF Department of Family and Community Medicine and Medical Director, Osher Center for Integrative Medicine. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [11/2013] [Health and Medicine] [Show ID: 25721]
UCSF Radiology Research
UCSF Department of Radiology and Biomedical Imaging Research.
Views: 47 UCSF Imaging
NETRF Bay Area NET Patient Education Conference - 11 Clinical Trials
NETRF Bay Area NET Patient Education Conference Stanford Cancer Center & NET Research Foundation 2.4.2017 www.netrf.org Emily Bergsland, MD Professor of Clinical Medicine, Helen Diller Family Comprehensive Cancer Center, UCSF Dr. Emily Bergsland is a professor of clinical medicine at the University of California, San Francisco (UCSF). She holds the Ernest Rosenbaum, MD Endowed Chair in Medical Oncology and is the director of the Hematology/Oncology Fellowship Program. Dr. Bergsland earned her medical degree from the University of Minnesota and performed her internal medicine training at UCSF. She subsequently completed a fellowship in Medical Oncology, and a training program in Molecular Medicine, before joining the UCSF faculty in 1998. Dr. Bergsland is a gastrointestinal oncologist with a clinical research effort focused on novel therapies for neuroendocrine tumors. She is co-chair of the Neuroendocrine Tumor Task Force of the National Cancer Institute (NCI) Gastrointestinal Steering Committee, a member of the NCCN Neuroendocrine Tumors Guidelines Panel, and a member of the Board of Directors of the North American Neuroendocrine Tumor Society (NANETS).
Welcome and Opening Remarks - 4th Annual Symposium on Global Cancer Research
Welcome and Opening Remarks Lisa Stevens, PhD, Deputy Director, Center for Global Health, National Cancer Institute (NCI), National Institutes of Health, U.S. Department of Health and Human Services Bev Mitchell, MD, Director, Stanford Cancer Institute Alan Ashworth, PhD, FRS, President, UCSF Helen Diller Family Comprehensive Cancer Center 4th Annual Symposium on Global Cancer Research Hilton San Francisco Union Square April 8, 2016
Views: 32 GlobalOnc
Understanding the Basics of Clinical Oncology from Diagnosis to Treatment
(Visit: http://www.uctv.tv/) Dr. Andrew Ko, UCSF Comprehensive Cancer Center, provides definitions and terms used in cancer diagnosis and treatment. He explores the process of diagnosis from biopsies to imaging and how staging is established. He also discusses the multimodality approach to treatment which typically includes surgical oncology, medical oncology and radiation oncology. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [10/2013] [Health and Medicine] [Show ID: 25630]
How To Catch Breast Cancer Early: Stanford Doctors Explain Mammography Options
There are several breast cancer detection options, and it is recommended that all women over age 40 get their mammograms. It has been shown that regular screening can catch breast cancer early and save lives. Stanford radiologists Drs. Debra Ikeda and Jafi Lipson explain the different types of imaging available and also explain the newest technology, tomosynthesis, or 3D mammography. Visit: http://stanfordhealthcare.org/bcaware
Views: 38241 Stanford Health Care
CLOSING REMARKS - 4th Annual Symposium on Global Cancer Research
Ami Bhatt, MD, PhD, Stanford University Katherine Van Loon, MD, MPH, UCSF 4th Annual Symposium on Global Cancer Research Hilton San Francisco Union Square April 8, 2016
Views: 69 GlobalOnc
Early Diagnosis of Cancer: Imaging at the Molecular Level
(May 25, 2010) Dr. Sam Gambhir M.D., PhD., Professor of Nuclear Medicine at the Stanford University Medical School, discusses how nuclear medicine and different imaging techniques can be used to diagnose cancer and other diseases at early stages at the molecular level. During the final quarter of the Stanford Mini Med School, some of the most timely and important topics in contemporary medicine and the biosciences are addressed. Stanford Mini Med School is a series arranged and directed by Stanford's School of Medicine and presented by the Stanford Continuing Studies program. Stanford University: http://www.stanford.edu Stanford Medical School: http://med.stanford.edu/ Stanford Continuing Studies: http://continuingstudies.stanford.edu/ Stanford University Channel on YouTube: http://www.youtube.com/stanford
Views: 10373 Stanford
Advances in NET Treatment
With Dr. Pamela Kunz, Stanford, Dr. Brenda Visser, Stanford, Dr. Arthur Sung, Stanford, and Dr. Emily Bergsland, UCSF
Views: 1640 Caring4Carcinoid
Stanley Falkow (Stanford University) Part 2: Helicobacter pylori and Gastric Cancer
https://www.ibiology.org/microbiology/host-pathogen-interactions-human-disease/#part-2 Lecture Overview Ninety percent of the cells humans carry are microbes. Only a few of the bacteria we encounter are pathogenic and can cause disease. Pathogens possess the inherent ability to cross anatomic barriers or breach other host defenses that limit the microbes that make up our normal flora. A significant part of human evolution has gone into developing ways to thwart microbial intrusion. In turn, microbes have come up with clever ways to avoid and circumvent host defenses but human — microbe interactions is still a "Work in Progress." When we study pathogens we learn as much about ourselves as we do about them. Helicobacter pylori lives in the human stomach. It causes gastritis, ulcer disease and even gastric cancer. Some H. pylori can inject a protein, CagA, into gastric epithelial cells. CagA interacts with the tight junctions that bind cells together and with signaling molecules affecting motility and proliferation. CagA is associated with ulcer disease and cancer but we don't understand how it works to favor malignancy. Not long ago in history most humans carried H. pylori ; the incidence of carriage and gastric cancer is dropping but there is evidence that this microbe also had a protective effect on human health.
Views: 14966 iBiology
The sugar coating on your cells is trying to tell you something | Carolyn Bertozzi | TEDxStanford
In her talk about sugar and cancer, Stanford Chemistry Professor Carolyn Bertozzi tells us why the sugar coating on our cells is crucial to our health and well-being. Unlike the sugar coating on a peanut M&M, she explains, human cells are covered with complex sugars Bertozzi shows us are, “like foliage swaying in the breeze.” The language these sugars are speaking can tell us everything from what blood type we are to whether we have cancer. Carolyn Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry and Professor of Chemical & Systems Biology and Radiology (by courtesy) at Stanford, and an investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree at Harvard and her doctorate at UC Berkeley. After postdoctoral work at UCSF and a professorship at UC Berkeley, she joined the faculty at Stanford coincident with the launch of Stanford ChEM-H. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Views: 50974 TEDx Talks
UCSF Researchers Control Embryonic Stem Cells With Light
UC San Francisco researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue. Read more: http://tiny.ucsf.edu/7eHzI7 Director: Arezu Sarvestani Producer: Sara Shaffer PIO: Nicholas Weiler
Immunotherapy, a new weapon against cancer
Dr. Jon LaPook introduces us to the next frontier of cancer treatment: immunotherapy, in which the body's own immune system is genetically modified to detect and destroy cancer cells. Subscribe to the "CBS Sunday Morning" Channel HERE: http://bit.ly/20gXwJT Get more of "CBS Sunday Morning" HERE: http://cbsn.ws/1PlMmAz Follow "CBS Sunday Morning" on Instagram HERE: http://bit.ly/23XunIh Like "CBS Sunday Morning" on Facebook HERE: http://on.fb.me/1UUe0pY Follow "CBS Sunday Morning" on Twitter HERE: http://bit.ly/1RquoQb Follow "CBS Sunday Morning" on Google+ HERE: http://bit.ly/1O3jk4x Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B --- "CBS Sunday Morning" features stories on the arts, music, nature, entertainment, sports, history, science, Americana and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.
Views: 3109 CBS Sunday Morning
Promise and Challenge of Personalized Cancer Therapy
Tailoring cancer treatments to the individual has long held the promise of better results. Martin McMahon, Professor of Cancer Biology at the UCSF Helen Diller Family Comprehensive Cancer Center provides a look at the promise and the challenge of personalized therapy. Series: UCSF Mini Medical School for the Public [10/2010] [Health and Medicine] [Show ID: 19612]
Bench to Bedside: Autism Spectrum Disorder, part 2 - From Genes to Pathology - Matthew State (UCSF)
Dr. Bryan King introduces the autism spectrum disorder (ASD), and Dr. Matthew State overviews the hunt for genes associated with autism. https://www.ibiology.org/human-disease/autism-spectrum-disorder/ Talk Overview: In the first lecture, Dr. Bryan King introduces the autism spectrum disorder (ASD) and defines the clinical criteria that characterizes ASD. Although there is no universal drug that is used to treat ASD, there are multiple medications used in the setting of autism. King outlines the different drugs used to treat the core behavioral features of autism as well as psychiatric disorders associated with autism (e.g. ADHD and anxiety), and discusses the challenges and problems with designing clinical trials to study drugs to treat ASD, specifically with the heterogeneity of the ASD population. In the second lecture, Dr. Matthew State overviews the hunt for genes associated with autism and explains how studying de-novo rare mutations in the germline has advanced the understanding of the genetics of autism spectrum disorder (ASD). Studying a cohort of families with one affected individual and one unaffected sibling, they were able to map multiple genes involved in ASD. Because of the complexity of the developing brain, the same gene could act upon different regions of the brain at different times during development. Therefore, after identifying genes associated with ASD, they characterized the region and time during development where these genes are expressed and more likely to have an effect that is associated with ASD. Speaker Biography: Dr. Matthew State is the Oberndorf Family Distinguished Professor and Chair of Psychiatry at the University of California, San Francisco and President of the Langley Porter Psychiatric Hospital and Clinics. He obtained his bachelor’s degree from Stanford University (1984) and received his medical degree from Stanford Medical School (1991). He continued his medical training at the UCLA Neuropsychiatric Institute specializing in Child Psychiatry, and completed a doctorate degree in genetics at Yale University (2001). State was a faculty member at Yale University from 2001 to 2013. In 2014, he joined the faculty at UCSF where his laboratory studies the genetics and genomics of developmental neuropsychiatric disorders, with a particular interest in Autism Spectrum Disorder and Tourette Disorder. For his scientific contributions, State received the Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine (2017), and was elected member of the National Academy of Medicine (2014). Learn more about State’s research at his lab website: http://www.mstatelab.com/
Views: 531 iBiology
Jim Wells and Michelle Arkin(UCSF) Part 1: Introduction to Drug Discovery
https://www.ibiology.org/archive/introduction-drug-discovery-process/ The modern drug discovery process integrates our deepest understanding of the molecular basis for disease with fundamental understanding of how potential drug molecules interact with specific disease targets and the whole organism. These two lectures are intended to give a broad and general introduction to the drug discovery process. Part I focuses on the early stages of drug discovery. We describe the basic stages of the drug discovery process, beginning with how disease targets are identified. We then take you into the laboratory to show you how a popular approach, high throughput screening, is used to identify! compounds that can engage the molecular target or pathway of interest. See more at http://www.ibioseminars.org
Views: 34557 iBiology
Eli Van Allen: Clinical computational oncology for precision medicine
The ability to create increasingly complex genomic data generated directly from patient tumors may impact our understanding of cancer and affect clinical decisions about cancer treatment. As the quantity of genomic data generated from individual cancer patients greatly expands, innovations will be needed to successfully implement large-scale genomics at the point-of-care. These include new ways to 1) interpret large-scale data from individual patients and 2) understand why patients respond (or don't respond) to existing and emerging cancer therapies such as targeted therapies, chemotherapies, and immunotherapies. In this talk, Dr. Van Allen explores how the emerging discipline of clinical computational oncology is powering new approaches for the clinical interpretation of large-scale genomic data and how these data are helping physicians understand why certain patients benefit from cancer therapies when others do not. While still in its infancy, this new field of clinical computational oncology may drive the widespread implementation of precision cancer medicine in the years to come. Eli Van Allen, M.D. A postdoctoral research fellow at the Broad, Eli Van Allen is an Instructor in Medicine at Harvard Medical School and an oncologist at Dana-Farber/Partners Cancer Care, with a focus on genitourinary cancers. His research melds his background in computer science with cancer genomics in order to develop algorithms that analyze and interpret genomic data to help patients. This research is at the front lines of precision cancer medicine, including understanding why resistance develops and identifying targeted therapies for patients. A native of Los Angeles, Eli studied Symbolic Systems, an inter-disciplinary major at Stanford University that applies computer science to other academic disciplines, including linguistics and neuroscience. While at Stanford, he helped found Camp Kesem, a summer camp for children whose parents have cancer. This experience sparked his interest in oncology, and as a medical student, he realized that his talents in computer science could help propel advances in the field. (Eli still volunteers at Camp Kesem, which now has locations throughout the United States.) After graduating from Stanford in 2003, Eli received his M.D. from UCLA, and completed a residency in internal medicine at UCSF before coming to Boston and completing a medical oncology fellowship at the Dana-Farber/Partners Cancer Care program. Copyright Broad Institute, 2015. All rights reserved.
Views: 2175 Broad Institute
Patient Specific Stem Cells for Precision Medicine
Joseph Wu, MD, PhD, Professor of Medicine at Stanford University, discusses the use of patient-derived induced pluripotent stem cells in cardiovascular research. *Note: the first minute or two of the lecture was not recorded due to technical issues.
Views: 135 UCSF-Stanford CERSI
Sue Biggins (Fred Hutchinson Cancer Research Center, HHMI) 1: Chromosome Segregation
https://www.ibiology.org/ibioseminars/chromosome-segregation.html Proper chromosome segregation during cell division is critical to ensure that daughter cells inherit the correct number of chromosomes. Microtubules emanating from the spindle poles pull on sister chromatids to move one chromosome to each pole. The kinetochore, a protein complex on the chromosome, is key to regulating chromosome segregation. Kinetochores form attachments to microtubule ends (no easy feat since microtubules are constantly growing and shrinking), they sense tension to ensure that sister chromatids are connected to microtubules from opposite poles, and they signal the cell to stop cell division if attachment is not correct. Biggins gives an excellent overview of kinetochore structure and its critical functions in chromosome segregation. When Biggins began working on kinetochores, the experiments that she could do were limited by the lack of a method to purify intact kinetochores. In Part 2 of her talk, Biggins explains how her lab purified kinetochores from yeast (for the first time ever!). They showed that the purified protein complex functioned in the same manner in vitro as endogenous kinetochores. Using electron microscopy and other techniques, Biggins and her collaborators were able to visualize the structure of the kinetochore-microtubule attachment and demonstrate, surprisingly, that tension directly stabilizes the attachment. Speaker Biography: Dr. Sue Biggins studied biology as an undergraduate at Stanford University and initially thought she would apply to medical school after receiving her degree. However, after a summer working in a research lab, she changed her mind and decided to apply to graduate school. Biggins received her PhD in molecular biology from Princeton and was a post-doctoral fellow with Andrew Murray at the University of California, San Francisco. Currently, Biggins is a Principal Investigator in the Division of Basic Sciences at the Fred Hutchinson Cancer Research Center and an Investigator of the Howard Hughes Medical Institute. Her lab studies the kinetochore and how it regulates chromosome segregation. Chromosome mis-segregation results in aneuploidy, a common hallmark of cancer as well hereditary birth defects. Biggins’ groundbreaking research has been recognized with numerous honors. In 2013, Biggins received the National Academy of Sciences Award in Molecular Biology and the Hutchinson Center McDougall Mentoring Award. In 2015, she was awarded the Novitski Prize from the Genetics Society of America, and was elected to the National Academy of Sciences. Learn more about Dr. Biggins’ research here: http://research.fhcrc.org/biggins/en.html
Views: 3408 iBiology
Virtual Reality (VR) Pain Relief UCSF Benioff Childrens Hospital Oakland
Study at UCSF Benioff Children’s Hospital Oakland testing the use of virtual reality technology to help manage pain. The Virtutal Reality Goggles distracts patients from their pain. The mind can only focus on so much stimulation at once and given something else to focus on, the pain a person experiences will diminish. Patient, Briana, exhausted from days of nearly unbearable pain is transformed just a half an hour later, while interacting with a virtual reality game. VR pain management research to study how immersive virtual reality therapy can be used to reduce pain is ongoing at UCSF Benioff Children's Hospital Oakland.
Stem Cells: The Hope The Hype and the Science
Stem cells have the potential to transform the way scientists study human diseases, the way drug companies discover and test new drugs, and the way physicians treat their patients. Join Dr. Arnold Kriegstein, professor of neurology and director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF as he dispels the hype and explains the science that is at work. Series: UCSF Mini Medical School for the Public [12/2010] [Health and Medicine] [Show ID: 19614]
The CRI Irvington Postdoctoral Fellowship Program: Supporting Tomorrow's Breakthroughs Today
Basic research into the immune system is the foundation on which the entire field of cancer immunotherapy is built. Learn how the Cancer Research Institute (CRI) supports this important work through its Irvington Postdoctoral Fellowship Program. Featuring CRI postdoctoral fellows Paola Betancur, Ph.D., Stanford University School of Medicine; Matthew Gubin, Ph.D., Washington University School of Medicine; Ed Roberts, Ph.D., UCSF; Kristen Pauken, Ph.D., University of Pennsylvania School of Medicine; Roy Maute, Ph.D., Stanford University School of Medicine.
The Future of Personalized Medicine: Panel Discussion
UCSF Helen Diller Family Cancer Research Building Opening Day Panel on the Future of Personalized Medicine. Features Dr. Susan Desmond-Hellmann, Brook Byers, Craig Venter and Frank McCormick.
David Julius (UCSF): How peppers & peppermint identified sensory receptors for temperature and pain
https://www.ibiology.org/neuroscience/sensory-receptors/ How do we perceive our surroundings, the things we smell, hear or even feel? Dr. David Julius explains how his lab used natural products, such as capsaicin from chili peppers and menthol from peppermint, to identify sensory receptors that detect both temperature and pain. Speaker Biography: Dr. David Julius is a Professor in the Department of Physiology at the University of California, San Francisco. His laboratory was the first to identify the sensory receptors involved in detecting both temperature and the natural heating and cooling agents found in foods such as chili peppers and mint. Julius was elected to the National Academy of Sciences in 2004 and the American Academy of Arts and Sciences in 2005. He was awarded the Shaw Prize in 2010.
Stanford introduces 11th president, Marc Tessier-Lavigne
After unanimous approval by the Stanford Board of Trustees, Marc Tessier-Lavigne was introduced as Stanford's next president. Tessier-Lavigne's day on campus included meeting members of the Stanford community at several events such as a meeting of the Faculty Senate. For more information: http://news.stanford.edu/features/2016/president-named/
Views: 3880 Stanford
Kirby Lee, PharmD, MA: The UCSF Model of Medication Safety & Management in Patients with Dementia:
18th Annual Updates on Dementia Conference Objectives: 1. Discuss the current status of dementia research, including new findings related to the cause and prevention of AD. 2. Describe the rationale behind experimental therapeutic approaches in the Alzheimer’s disease clinical spectrum and drug targets in clinical trials 3. Learn about a new model for medication safety and management. 4. Discuss approaches to inappropriate sexual behaviors in persons with dementia, including non-pharmacologic and pharmacologic method of treatments. 5. Communicate and demonstrate how music can be used to connect with and reanimate people living with dementia. 6. Learn about a new model of care for dementia targeting patients, caregivers and primary care providers to enhance quality of care, improve medication safety and optimize health outcomes with an interdisciplinary team augmented by innovative technology. 7. Highlight some opportunities and challenges of developing sustainable care for caregivers and promote capacity to experience positive aspects of caregiving. Schedule: Welcome and Introduction William Fisher, CEO https://youtu.be/_GiOWK48Gyg Cognitive aging and dementia: risk reduction strategies Victor W. Henderson, MD, MS https://youtu.be/Je6cMScb8E8 Update on experimental therapeutic approaches in the Alzheimer’s disease clinical spectrum Alireza Atri, MD, PhD https://youtu.be/IF9NiYxyIc0 Questions & Answers William Fisher, CEO, Victor Henderson, MD, MS, Alireza Atri, MD, PhD https://www.youtube.com/watch?v=M20XH... Sexuality & Dementia Mehrdad Ayati, MD https://youtu.be/t-dKVo79v0o Connecting with people with dementia through the power of music Beatie Wolfe https://youtu.be/zh8C2uKjmNg Kirby Lee, PharmD, MA, MAS: A new model of medication safety and management in patients with dementia: the UCSF care ecosystem medication module https://youtu.be/6SzTFnCFYlY Alma Au, PhD: The challenges of emotional regulation for caregivers https://youtu.be/64DWAFVIxiI Sheung-Tak Cheng, PhD: Empowering dementia caregivers through building capacity for positive gains https://youtu.be/bYLFKdMPvA0 Dolores Gallagher-Thompson, PhD, Alma Au, PhD, Sheung-Tak Cheng, PhD: Questions and Answers https://youtu.be/92uS25GXSK8 Filmed and Edited by Jack Downey Media Coordinator Stanford Geriatric Education Center (SGEC)
Overview of Gynecologic Cancers
(Visit: http://www.uctv.tv/) Learn about the risk factors, prevention and treatment of gynecologic cancers: ovarian cancer, uterine (endometrial) cancer, and cervical cancer Recorded on 02/21/2017. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [5/2017] [Health and Medicine] [Show ID: 32075]
Redefining Possible: Tailor-Made Treatments for Childhood Leukemia
See how leading-edge science combined with hands-on care at UCSF Benioff Children's Hospitals gives kids and their families new reasons to hope.
Views: 2568 UCSFMedicalCenter
Patient Testimonial #8
One of Dr. Gholami's patients offers a testimonial of his experience with his prostate cancer treatment... "- I got the diagnosis of prostate cancer in 2008. - I saw 5-6 doctors before Dr. Gholami, at Stanford, Palo Alto Medical Foundation, and UCSF. - All of the doctors were worried about my medical history and previous surgeries. I had 4 major surgeries in Russia, including having my large intestine removed for ulcerative colitis. I then had several additional surgeries. - Other doctors refused to do the surgery and recommended seeds. Another doctor recommended hormone therapy. - At UCSF, they recommended seeds or hormones. - At Stanford, it was awful. They recommended only seeds. They said if you do robotic surgery, you will only have a 25% chance of success. - One of my friends recommended Dr. Gholami to me. - I made a spreadsheet with all of the recommendations I had received and gave it to Dr. Gholami the first time we met. - He thought about it and recommended robotic surgery. He said if I chose robotic surgery, there would be a 75% chance of success. - Although I didn't know Dr. Gholami, I believed him. He said if he couldn't make it with a good result, he would stop and recommend another method. He said if I was his father, he would recommend robotic surgery. - I didn't know Dr. Gholami's motivation. Maybe he's a risky person or it trying to grow his business. But I believed him. It was a feeling. - I'm an engineer. I can make a good analysis. - He told me he got a few gray hairs after the surgery. He repaired my hernia too. I feel better now. - It was a difficult time after surgery. I lost my erections. But I'm 70 years old, so that would have probably been a problem anyways. - I had 2 possibilities: life or no life. - I'm very grateful to Dr. Gholami."
Views: 30 DrGholamiSurgery
Clinical Research in Neuroendocrine Tumors - Dr. George Fisher
On September 25, 2010 the Caring for Carcinoid Foundation held its first Neuroendocrine Tumor Patient Education Conference at Stanford University's Alumni Center in Palo Alto California, USA. This day-long event was attended by over 100 patients and caregivers and featured neuroendocrine tumor experts from Stanford University and UCSF Medical Center.
Views: 282 Caring4Carcinoid